Article Outlines How Health Plans Utilize RWE for Specialty Drug Coverage
Health plans' use of real-world evidence for specialty drug coverage decisions is generally varied in terms of the number and [...]
Waystar: Poor Price Transparency is ‘Single Biggest Issue’ in Patient’s Financial Experience
In a sponsored article on HealthLeaders Media, Waystar outlines the patient's need for more "financial clarity" during their health care [...]
eyeforpharma Philadelphia Pivots to Virtual Event
In response to the COVID-19 outbreak, eyeforpharma is transitioning its eyeforpharma Philadelphia conference to a free, online event. The 4-day [...]
NICE Publishes COVID-19 Guidelines
The National Institute for Health and Care Excellence (NICE) on March 21 published a new set of guidelines that address [...]
Webinar – Faster to Market: Transforming HEOR & RWE Using Virtual Sourcing
Wish you could get HEOR & RWE projects started faster, cheaper, & using the most optimal vendor? Do you want [...]
Blog Post Mulls Indirect Benefits in Value Assessments
A recent blog post published on Health Affairs highlights some key reasons why indirect benefits should be factored into value [...]
Predictions for RWE in 2020
A recent article published on PharmaTimes looks at what the future may hold for real-world evidence amid rising interest in [...]
Lin: Clinical Practice Guidelines Not Broken
Family physician and Common Sense Family Doctor blogger Kenneth Lin in a recent post published on MedPage Today writes that [...]
ICER Indefinitely Postpones Public Meetings, Expands Assessment Timelines
In response to the COVID-19 pandemic, the Institute for Clinical and Economic Review (ICER) announced it would indefinitely postpone several [...]
AMCP Cancels Annual Meeting
The Academy of Managed Care Pharmacy (AMCP) has canceled its annual meeting, which was set to begin April 21, saying [...]
Pfizer Offers Its Resources in Fight Against Coronavirus
Pfizer is entering the fight against coronavirus after announcing it would offer its resources for wider use, FiercePharma reports. The [...]
ICER Posts Reports Outlining Two Planned Reviews
The Institute for Clinical and Economic Review (ICER) on Friday, March 13, posted two new draft scoping documents outlining planned [...]
U.S. Looks to Limit Out-of-Pocket Costs for Insulin Under Medicare
The Trump administration announced a new plan to limit the out-of-pocket costs for insulin to $35 month for Medicare patients, [...]
RWE 2020 Postponed Until Later This Year
The Real-World Evidence 2020: Rare Diseases and Innovative Therapies event has been postponed to later this year in response to [...]
Webinar to Outline Key Takeaways of ICER’s Updated Value Framework
Boston Healthcare Associates is slated to highlight the Institute for Clinical and Economic Review's (ICER) updated value assessment framework in [...]
AMCP Seeks Session Proposals for Nexus 2020
The Academy of Managed Care Pharmacy (AMCP) has issued a call for education session proposals as it gears up for [...]
Welltok’s Smith Discusses SDOH
Welltok Consumer Journey Director Jodi Smith in a recent write up published on Modern Healthcare Executive says payers and providers [...]
Cantrell Highlights Updated AMCP Format
Academy of Managed Care Pharmacy (AMCP) CEO Susan Cantrell in a blog post says the AMCP Format 4.1 features new [...]
HIMSS Cancels 2020 Meeting Amid Coronavirus Concerns
In response to recent reports on the coronavirus from the World Health Organization and the Centers for Disease Control and [...]
ICER Launches New Suite of Interactive Tools
The Institute for Clinical and Economic Review (ICER) recently announced a new set of interactive tools that could serve as [...]
Course Correction in Precision Medicine ‘Urgently Needed,’ Cooper, Paneth Say
"A course correction is urgently needed," Loyola University Medical School's Dr. Richard Cooper and Michigan State University's Nigel Paneth write, [...]
Oscar Health’s $3 Drug List Looks to Boost Adherence, Lower Pricing
In an effort to bolster patients' medication adherence while also reducing drug spending, Oscar Health developed the $3 Drug List. [...]
Advance Registration Deadline for AMCP 2020 Nears
The deadline for advance registration for the Academy of Managed Care Pharmacy's (AMCP) annual meeting in Houston is midnight PST [...]
Using RWD for Rare Diseases
OM1's Kathryn Starzyk, senior director of real-world evidence, in a recent tHEORetically Speaking blog post outlines how real-world data tools [...]
Report: FDA Program Leads to Billions in Price Increases
A program launched in 2006 by the Food and Drug Administration (FDA) helped ensure the safety and effectiveness of older [...]